Date Title Description PDF
22 Feb 2022 On buy-back programmes ROVI reports the end of the share buy-back programme, effective as of 3 November 2021, and the launching of a new share buy-back programme, effective as of 23 February 2022.     Download
16 Feb 2022 On business and financial situation Moderna and ROVI announced that they expand their long-term collaboration for the manufacture of mRNA medicines over the next ten years       Download
03 Nov 2021 On buy-back programmes The Company reports the commencement, effective as of today, 3 November 2021, of a share buyback program. Download
16 Jul 2021 On Corporate Governance ROVI announces the appointment of Juan López-Belmonte Encina as Chairman of the Company   Download
22 Jun 2021 On significant placements in financial instruments Bestinver announces the beginning of an accelerated book build process of up to a 3% of the share capital of Laboratorios Rovi, S.A. Download

Pages

55 / 63
Date Title Description PDF
02 Oct 2025 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the third quarter of 2025 Download
04 Jul 2025 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the second quarter of 2025 Download
03 Jul 2025 Other relevant information The Company informs about the dividends payment.  Download
18 Jun 2025 Announcement of general shareholders’ meeting The Company reports on the resolutions adopted by the Ordinary General Shareholders' Meeting and by the Board of Directors. Download
08 May 2025 On business and financial situation The Company releases the press release related to the first three months of 2025 financial results Download

Pages

10 / 175
Date Title Description PDF
08 Nov 2012 Composición Consejo de Administración Download
18 Sep 2012 Otros sobre negocio y situación financiera Download
26 Jul 2012 Información sobre resultados (2) Download
26 Jul 2012 Información sobre resultados Download
26 Jul 2012 Información financiera intermedia Download

Pages

175 / 194